ARTICLE | Clinical News
AEOL 10113 and other manganic porphyrin antioxidants regulatory update
September 11, 2000 7:00 AM UTC
Duke University (Durham, N.C.) received U.S. Patent No. 6,103,714 covering manganic porphyrin complexes, which catalytically degrade superoxide and peroxynitrite, and their use in imparting oxidoreductase (antioxidant) activity. INCR, which is the exclusive licensee of the patent, said the compounds could be useful to treat stroke and inflammatory diseases. ...